2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, OCTOBER 22, 2025 |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY
SINCE 2020 |
THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG) FOR ALL
"MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " DISCUSS AND UPDATE THE LEGISLATIVE PRIORITIES FOR
2025/2026
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S AND PATIENT INPUT PORTALS ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
REF'S ISSUES AND SOLUTIONS
TIME TO RENEW YOUR MEMBER IN FMCPG
CLICK HERE FOR THE MEMBERSHIP FORM USE THIS LINK TO REGISTER FOR THE NEXT MEETING - WEDNESDAY, NOVEMBER 5, 2025 CLICK ON LINK BELOW |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA
ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500 AND INCLUDES A ONE YEAR MEMBERSHIP IN THE FMCPG **Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF
MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
Trulieve Cannabis Corp. to Hold Third Quarter 2025 Results Conference Call on November 5, 2025
Oct. 15, 2025 -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Wednesday, November 5, 2025 at 8:30 AM Eastern Time following the release of its third quarter 2025 financial results.
Chairman, Founder, and Chief Executive Officer Kim Rivers and Chief Financial Officer Jan Reese will participate on the call to review Trulieve's financial and operating results.
Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call and ask to join the Trulieve Cannabis Corp. call. North American toll free: 1-844-824-3830 Passcode: 9870622
International: 1-412-542-4136 Passcode: 9870622
A live audio webcast of the conference call will be available at:
Trulieve Third Quarter 2025 Results Call An archived replay of the webcast will be available at:
https://investors.trulieve.com/events |
Trulieve Rewards Trulieve Rewards is a customer rewards program offering patients and customers in participating states an easy platform to earn points on every purchase at Trulieve dispensaries. We've revamped and refreshed our old cannabis loyalty program to reward cannabis enthusiasts loyal to Trulieve with savings, perks, and points every time they shop for cannabis products JOIN NOW |
Verano Elevates Expanding Vape Product Portfolio with Exclusive, First-to-Market Launch of Revolutionary HYPHEN System
HYPHEN features brand new best-in-class technology that allows consumers to flex between extracts, size formats and brands through interchangeable vape pods
CHICAGO, Oct. 16, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of HYPHEN, driving further momentum for the Company’s expanding vape portfolio with the exclusive rollout of HYPHEN’s all-in-one pod system. With a modular battery design that utilizes pod-functionality to serve multiple oil and volume categories within the same base unit, HYPHEN offers consumers the freedom and flexibility to use a variety of oils, sizes and formats without the hassle of juggling between different devices.
Beginning October 18, HYPHEN will hit dispensary shelves across a number of the nation’s largest cannabis markets – starting with Zen Leaf dispensaries and third-party retailers in Arizona, Illinois, Maryland and New Jersey, with plans to introduce it to Connecticut, Florida, Nevada, Ohio, Pennsylvania, Virginia and West Virginia thereafter. HYPHEN units will include a side-bar battery and pod – available in 1-gram (the) Essence and 2-gram Savvy pods – and individual pods will be available for purchase at a later date. Featuring 20 top-performing strains, (the) Essence pods will feature powerhouse strains including Pineapple Express and Gelato, with Savvy pods leaning on consumer-loved flavor profiles with a cannabis twist, such as Grape Kush and Blue Raz Haze.
READ MORE |
Verano Announces Grand Opening of Zen Leaf Antwerp in 19th Century Historic Ohio Train Depot, Offering Cannabis Consumers One of the Most Unique Dispensary Shopping Experiences in the U.S.
Zen Leaf is Located in Antwerp’s Norfolk & Western Train Depot Originally Built in 1880 and Listed on the National Register of Historic Places
Located at 503 W. River Street, Zen Leaf Antwerp is situated less than five miles from the Indiana border and just a 30-minute drive from Fort Wayne, Indiana’s second most populous city with more than 423,000 metro area residents1
Zen Leaf Antwerp is Verano’s sixth Ohio dispensary, expanding the Company’s statewide vertical footprint that includes Zen Leaf locations in Bowling Green, Canton, Cincinnati, Dayton and Newark, and 22,000 square feet of state-of-the-art cultivation and processing operations in Canton
During Grand Opening weekend, Zen Leaf Antwerp is hosting a job fair onsite at the dispensary October 17th and 18th from 10:00 a.m. to 6:30 p.m., offering aspiring cannabis professionals the opportunity to apply and interview for a variety of positions
Verano’s active operations span 13 states, comprised of 158 dispensaries and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity
Oct. 15, 2025 — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the Grand Opening of Zen Leaf Antwerp, located at 503 W. River Street, on October 17, raising the Company’s Ohio dispensary footprint to six statewide locations. Zen Leaf Antwerp will be open Monday through Saturday from 10:00 a.m. to 7:00 p.m. local time.
Zen Leaf Antwerp – situated in the Norfolk and Western Train Depot built in 1880 and listed on the National Register of Historic Places – offers one of the most unique dispensary shopping experiences in the U.S. given its rich history and aesthetic. After opening for curbside pickup earlier this year, Zen Leaf Antwerp’s Grand Opening follows the completion of interior and exterior restoration efforts focused on preserving and honoring the building’s historic character and legacy. The dispensary is also located just five miles from the Indiana border and a 30-minute drive from Fort Wayne, Indiana’s second largest metro area with more than 423,000 residents1.
READ MORE |
Planet 13 Continues Florida Expansion, Opening its New Pace Dispensary on a Busy Retail Corridor near Pensacola
Oct. 20, 2025 — – Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the opening of its newest Florida dispensary in Pace at 4612 School Lane just off busy US Highway 90.
Located along a bustling retail corridor directly across from a Walmart and Lowe’s, Planet 13 Pace will be open Monday through Saturday from 9 a.m. to 7 p.m. and from 11 a.m. to 5 p.m. on Sundays, 365 days a year. Pace is one of the fastest-growing communities in the Panhandle, known for its family-friendly neighborhoods and welcoming small-town atmosphere.
“We’re thrilled to expand our presence along Florida’s beautiful panhandle, and we look forward to serving patients in Pace and the nearby communities of Milton, Bagdad and Avalon with Planet 13’s best-in-class cannabis products and unmatched customer service,” said Bob Groesbeck, Co-CEO of Planet 13. “Our location is in the heart of the busiest shopping district in the area and Planet 13 is excited to provide quality care and a local, community-focused experience.”
READ MORE |
This week's Viridian Chart of the Week revisits an analysis that we last published on 10/20/22. At that time, we reasoned that high leverage, in terms of total liabilities to market cap and low liquidity as measured by the Viridian Liquidity Score, in conjunction with tight capital markets, could lead to heightened risk of restructuring.
We have used the same criteria we used in our original study: Viridian Liquidity Score under 1.2x and Total Liabilities to Market Cap of over 2x.
Our original screening revealed ten companies: Acreage, Cansortium, Body & Mind, Tilt, StateHouse, MedMen, Iconic Brands, Unrivaled, CSL Holdings, and Red White & Bloom. Five of these companies (STHHZ, MMEN, UNRV, RWB, and ICNB have either restructured their balance sheets or liquidated.. Finally, two names from our earlier work, Body & Mind and Tilt Holdings, appear again on our new screening. |
Despite hitting our screen, we believe the two companies on the far left, MariMed and Jushi, are unlikely restructuring candidates. MariMed is ranked #13/25 in our weekly credit ranking, and Jushi ranks 15/25. Both have 1x liquidity or better, and both have over 1.2x asset coverage (derived from our option-based methodology). Of the two, Jushi carries a bit more risk in our opinion due to the $139M of 2026 debt maturities noted in its June 10Q, and the fact that the second priority notes are offered at yields above 20% according to Ventum Capital. Still, we believe the company will be able to roll its debt.
Liquidity, asset coverage, and the Viridian credit score are all worse for the Cannabist Company. CBST has been maintaining liquidity by selling non-core operations, but the numbers still show that things are tight. Asset coverage is only about .8x as the company is still significantly overleveraged. Its recent debt restructuring pushed out maturities but did nothing to reduce debt.
The rest of the list has more pressing liquidity concerns and less than .6x asset coverage. Both BAMM and Tilt have undergone multiple asset dispositions, which are reflected in their numbers. But despite these moves, the numbers appear relatively dire. We note also that BAMM has not filed its July 2024 10K or any subsequent 10Qs. We are working with out-of-date financials, and that opacity further increases our perception of risk.
Companies with low liquidity and high market leverage have proven historically to be high restructuring risks. Investors need to be aware that S3 is not a universal kick save that will bail these companies out. Investors who have these names in their portfolios should take a very close look. |
For More Analysis View This Week's Viridian Chart of the Week About Viridian Capital Advisors
Since launching in 2014, Viridian Capital Advisors has become one of the most respected and experienced advisory and M&A firms specializing in the cannabis industry. We provide a wide range of services, including: Strategic Advisory Consulting: Including valuation, financial modeling, restructuring and fairness opinions.
Mergers & Acquisitions: Transaction advisory and execution. Capital Raises: Including debt and equity. Many of our assignments begin with a basic question: "What should I do now?" Raise capital to expand? What kind of capital is most appropriate?
Acquire another company? What are the advantages and pitfalls?
Sell my company? What valuations can i achieve? What transaction structures are possible?
Put our experience, data and depth of senior talent behind your next transaction.
Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com
Frank Colombo
Managing Director
Viridian Capital Advisors, LLC
914.523.4730
fcolombo@viridianca.com
|
NATIONAL AND INTERNATIONAL NEWS |
Massachusetts Ballot Campaign to End Adult-Use Cannabis Market ‘On Track’ to Collect Enough Signatures
The petitioners aim to collect more than the 74,574 signatures needed to place ‘Version B’ of a prohibition initiative on the 2026 ballot.
The signature-gathering phase is “going well” for a coalition that’s aiming to put a question before Massachusetts voters that would backtrack on adult-use cannabis legalization by wiping out the state’s licensed industry.
Massachusetts Attorney General Andrea Joy Campbell certified the petition, “An Act to Restore a Sensible Marijuana Policy,” last month, and now the group has until Dec. 3 to collect 74,574 valid signatures from registered voters to have a shot at qualifying for the November 2026 ballot.
The campaign organizers aim to submit more than 100,000 signatures to the secretary of state, providing a cushion in anticipation of the state’s vetting process to ensure the signatures are valid, group spokesperson Wendy Wakeman told Cannabis Business Times.
READ MORE AT CANNABIS BUSINESS TIMES |
Politics Alcohol Industry Steps Up Lobbying On Hemp Drinks As Congress Debates THC Ban
The last three months have seen a surge in congressional lobbying from major alcohol companies and associations aiming to influence federal hemp laws, with a focus on THC beverages that many consumers are turning to as beer and liquor alternatives.
According to newly published lobbying disclosures from the 3rd quarter of 2025, a wide range of cannabis and alcohol interests put dollars toward various legislative issues, including marijuana banking, rescheduling, legalization and hemp regulations.
But there was an especially notable amount of lobbying activity around hemp THC beverages as Congress and state legislatures across the country discuss policy options for intoxicating cannabinoid products—with some pushing for an outright ban and others promoting a more rigorous regulatory framework that prioritizes public health and deterring youth access.
READ MORE AT MARJUANA MOMENT |
Akanda Corp. Increasing Its Cannabis Investment
October 20, 2025 – Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation license for a variety of potential products containing THC, but currently it is operating under its hemp cultivation license. A further extension of the license would highlight Akanda’s commitment to executing its strategic vision and assist in solidifying its role in the global cannabis industry.
The Company plans during this additional two year period to work towards developing Tetrahydrocannabinol (THC) and cannabidiol (CBD) assets at this site. Additional payments will be made based upon milestones achieved from the development. The milestones in the agreement include THC cultivation, sales of product, and CBD cultivation.
READ MORE |
Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Legal Cannabis Market
Oct. 17, 2025 — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, proudly celebrates the seventh anniversary of cannabis legalization in Canada. As the largest federally legal cannabis market in the world, Canada’s progressive regulatory framework has fostered innovation and created vast economic opportunities for Canadian businesses and communities and set the global benchmark for responsible cannabis legalization and industry development.
Blair MacNeil, President of Tilray Canada, stated, “Seven years ago, Canada made history by becoming the first G7 country to legalize cannabis nationwide, a bold step that has set a global benchmark. I am deeply honoured that Tilray played a pivotal role in this transformative journey, championing responsible growth while supporting Canadian innovation and leadership. This milestone is a celebration of our dedicated team, our unwavering commitment to excellence, and, above all, the trust and support of Canadian consumers, who have made this industry a source of national pride.”
Following Canada’s legalization of cannabis on October 17, 2018, Tilray Brands’ licensed producers—including Aphria, Broken Coast, Hexo, Redecan, and a portfolio of other market-leading brands—have consistently led at the forefront of the country’s cannabis industry, setting benchmarks for quality, safety, scale, and innovation. Tilray’s economic footprint extends nationwide, generating thousands of jobs through its sales, marketing, cultivation, and manufacturing operations. The company has invested over C$1 billion in Canadian infrastructure, paid approximately C$700 million in excise taxes, and contributed hundreds of millions in harmonized, goods and services and provincial sales tax. These substantial investments have helped legitimize the cannabis industry, advancing the goal of eliminating the illicit market and ensuring patient and consumer safety by providing quality-controlled, rigorously tested products. Importantly, Tilray has also helped change people’s lives by providing safe, thoroughly tested medical cannabis to patients in need, supporting their health and well-being while expanding access to effective treatment options. Additionally, Tilray actively supports local economies through supplier partnerships, service contracts, charitable contributions, and sustainable business practices, reinforcing its commitment to responsible corporate citizenship, environmental stewardship, and community development.
READ MORE |
PharmaTher Applauds FDA’s Commissioner’s National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale
October 17, 2025 – PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”), a specialty life sciences company focused on unlocking the pharmaceutical potential of ketamine, today applauds the U.S. Food and Drug Administration’s (“FDA”) announcement on October 16, 2025 of the first-ever recipients of the new Commissioner’s National Priority Voucher (“CNPV”) pilot program, which include “ketamine for domestic manufacturing of a critical drug for general anesthesia.” The pilot elevates ketamine as a national priority.
The CNPV is expected to a catalyst for the ketamine market—and PharmaTher is positioned at the forefront. By prioritizing ketamine, the FDA is signaling to hospitals, GPOs, and public buyers that on-shore, quality-assured supply is a national objective, potentially amplifying demand for reliable U.S. sources. At the same time, the program’s team-based review and ~1-2 month decision window reduce regulatory friction for aligned, complete filings, enabling faster conversion of supply into sales. Finally, ecosystem signals—public announcements referencing ketamine API under CNPV and the resolution of multi-year U.S. shortages (February 2018 to August 2025)—point to sustained momentum for ketamine.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 930,000
AND 736 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
OCTOBER 17, 2025 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) OCT 17 2025 930,093 OCT 10 2025 928,083
OCT 03 2025 926,467
SEPT 26 2025 925,084
SEPT 19 2025 924,797
SEPT 12 2025 924,473
Patients Last Week: 2,010
Qualified Ordering Physicians: 2,440 New Doctors Last Week: 1 Reporting Period: OCT 10 - OCT 916 2025
Amount of Medical Marijuana Dispensed - (mgs THC) 405,847,854
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 0
Amount of Marijuana in a From for Smoking (oz) 138,862.749
Approved Dispensing Locations: 736
ADDED LAST WEEK 0 |
UPCOMING MEETING AND CONFERENCES LOOK FOR IN FUTURE ISSUES |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|